Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Current Deferred Revenue data on record, last reported at $59.8 million in Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 71.25% year-over-year to $59.8 million; the TTM value through Dec 2025 reached $59.8 million, up 71.25%, while the annual FY2025 figure was $59.8 million, 71.25% up from the prior year.
  • Current Deferred Revenue reached $59.8 million in Q4 2025 per AHCO's latest filing, roughly flat from $59.9 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $59.9 million in Q3 2025 and bottomed at $22.3 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $37.3 million, with a median of $34.4 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 184.07% in 2021, then decreased 25.3% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $31.4 million in 2021, then rose by 0.86% to $31.6 million in 2022, then increased by 21.9% to $38.6 million in 2023, then fell by 9.4% to $34.9 million in 2024, then skyrocketed by 71.25% to $59.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $59.8 million in Q4 2025, $59.9 million in Q3 2025, and $56.3 million in Q2 2025.